Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Stenosis | 3 | 2026 | 107 | 0.620 |
Why?
|
| Endarterectomy, Carotid | 2 | 2026 | 64 | 0.440 |
Why?
|
| Endovascular Procedures | 2 | 2026 | 390 | 0.320 |
Why?
|
| Carotid Artery Diseases | 1 | 2026 | 70 | 0.230 |
Why?
|
| Clinical Decision-Making | 2 | 2026 | 364 | 0.220 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2025 | 61 | 0.210 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 1430 | 0.190 |
Why?
|
| Patient Participation | 1 | 2026 | 446 | 0.170 |
Why?
|
| Decision Support Techniques | 1 | 2026 | 480 | 0.170 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 33 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 45 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 96 | 0.130 |
Why?
|
| Stroke | 1 | 2025 | 1271 | 0.120 |
Why?
|
| Asymptomatic Diseases | 2 | 2025 | 104 | 0.110 |
Why?
|
| Endocytosis | 1 | 2014 | 168 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2014 | 137 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 372 | 0.090 |
Why?
|
| Stents | 2 | 2026 | 564 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 574 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2025 | 3752 | 0.060 |
Why?
|
| Europe | 1 | 2025 | 421 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2026 | 180 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 333 | 0.050 |
Why?
|
| Consensus | 1 | 2025 | 479 | 0.050 |
Why?
|
| Patient Preference | 1 | 2026 | 223 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2021 | 5 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 46 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10919 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2026 | 588 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2026 | 11794 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2123 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 322 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 422 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 426 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 2933 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2026 | 1420 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 740 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 630 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2021 | 601 | 0.030 |
Why?
|
| Receptors, Pheromone | 1 | 2014 | 3 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2131 | 0.030 |
Why?
|
| Pheromones | 1 | 2014 | 22 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1777 | 0.030 |
Why?
|
| Humans | 5 | 2026 | 145783 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2181 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3634 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2399 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 26217 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 668 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2014 | 414 | 0.020 |
Why?
|
| United States | 1 | 2025 | 16126 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 6033 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1764 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8347 | 0.010 |
Why?
|
| Male | 2 | 2025 | 73011 | 0.010 |
Why?
|
| Female | 2 | 2025 | 79045 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 14254 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 36309 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 40881 | 0.010 |
Why?
|